Evaluating costs and outcomes in cardiovascular disease Heather Patterson Newsletter Article 09 February 2013 Pages: 3 - 4
Improving the generalisability of pharmacoeconomic studies Newsletter Article 09 February 2013 Pages: 5 - 5
Formulary considerations for new non-HIV antivirals and antifungals Newsletter Article 09 February 2013 Pages: 5 - 5
Vancomycin use falls during pharmacy database analysis Newsletter Article 09 February 2013 Pages: 7 - 7
High rate of modification to antihypertensive therapy costly Newsletter Article 09 February 2013 Pages: 9 - 9
No insurance means less healthcare for US children Newsletter Article 09 February 2013 Pages: 11 - 11
Government and companies to negotiate drug prices in Italy Newsletter Article 09 February 2013 Pages: 11 - 11
Price of US prescription drugs up 2.3% in first quarter Newsletter Article 09 February 2013 Pages: 11 - 11